Researchers
SS headshot

Sukhbir Singh

MD, FRCSC, FACOG

Associate Scientist, Acute Care Research

Ottawa Hospital Research Institute

Chair, Obstetrics and Gynecology

University of Ottawa

Department Head, Obstetrics, Gynecology and Newborn Care

The Ottawa Hospital

Full Professor, Obstetrics and Gynecology

University of Ottawa

Contact

Obgynchairadmin@toh.ca

613-737-8899 x 71246

ORCID 0000-0002-2042-3751
@dr_sonysingh

Bio

Dr. Sukhbir (Sony) Singh is Professor and Chair of the Department of Obstetrics and Gynecology at the University of Ottawa and Head of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital. He is an Associate Scientist and past Dr. Elaine Jolly Research Chair in Gynecologic Surgery (2016-2025) at The Ottawa Hospital Research Institute.   

Upon completion of his medical training at the University of Western Ontario (MD 2000, FRCSC 2005), he completed fellowships in minimally invasive gynecologic surgery at the University of Toronto (2005-2006) and the University of Sydney, Australia (2006-2007). 

He has been active in promoting excellence in gynecologic surgery at the national and international level.  This includes his past roles as co-founder and Executive Director of CanSAGE (2016-2021) and past Board Member of the AAGL (2020-2023).

Dr. Singh leads the Ottawa Minimally Invasive Gynecology Research Group which focuses on the diagnosis, management and surgical approach to endometriosis and uterine fibroids. He has given over 450 presentations worldwide, delivered 50 formal courses and has over 150 publications to date. 

Research Goals and Interests

The Ottawa Minimally Invasive Gynecology Group at OHRI focuses on the following research areas:
 

  • Endometriosis:  Basic Science and Clinical Investigation
  • Uterine Fibroids:  Clinical Investigation
  • Health Services:  Improving Quality and Patient Experience of Surgical Interventions for Women
  • Education:  Surgical Education for Trainees (Residents/Fellows) and Practicing Surgeons

The Ottawa Minimally Invasive Gynecologic Surgery (OMIGS) Research Group is led by Dr. S. Singh (Lead Investigator) and includes a team of clinician researchers, research associates, surgical fellows and students.
Overall, the focus of this research group aligns around specific disease states, the delivery & education of surgical care and health care utilization.
The disease focus is “complex gynecologic conditions” and this includes endometriosis and uterine fibroids. Chronic pelvic pain, infertility and heavy menstrual bleeding are the main symptoms being evaluated. The surgical outcomes/procedures include hysterectomy, laparoscopy and hysteroscopy procedures.
 

News

Publications

Author Response: Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review

2019-01-01

Acute Abdominal Pain in a Postmenopausal Woman

2018-01-01

Age and sexual activity are risk factors for mesh exposure following transvaginal mesh repair

2011-01-01

How to treat endometriosis

2007-01-01
View More on ORCiD

Select Competitive Funding

2025 - 2030: CIHR - Ethnic and racial disparity in endometriosis pathobiology, diagnosis, and treatment ($1,055,700 CAD)

2025 - 2026: CIHR - Tackling Structural Determinants of Health Inequities for Racialized Populations in Canada ($125,000 CAD)

2022- 2024: The Ottawa Hospital Academic Medical Organization - Artificial intelligence applied to three-dimensional (3D) rendered models from MR imaging: Optimizing preoperative planning and surgical outcomes in patients with uterine fibroids ($100,000 CAD)

2020 - 2023: Physician Services Incorporated (PSI) - Characterisation of tissue stiffness to improve the diagnosis and management of uterine fibroids: The use of shearwave elastography to stratify treatment ($250,000 CAD)

 

Related Research at The Ottawa Hospital